Bilirubin in the Liver-Gut Signaling Axis

被引:173
作者
Hamoud, Abdul-Rizaq [1 ]
Weaver, Lauren [1 ]
Stec, David E. [2 ]
Hinds, Terry D., Jr. [1 ]
机构
[1] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA
[2] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res, Jackson, MS 39216 USA
关键词
INCREASES INSULIN SENSITIVITY; BILE-ACID TRANSPORTERS; PREGNANE-X-RECEPTOR; FATTY LIVER; SERUM BILIRUBIN; HEPATIC STEATOSIS; GILBERTS-SYNDROME; ENTEROHEPATIC CIRCULATION; UGT1A1-ASTERISK-28; ALLELE; BILIVERDIN REDUCTASE;
D O I
10.1016/j.tem.2018.01.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bilirubin is a component of the heme catabolic pathway that is essential for liver function and has been shown to reduce hepatic fat accumulation. High plasma bilirubin levels are reflective of liver disease due to an injurious effect on hepatocytes. In healthy liver, bilirubin is conjugated and excreted to the intestine and converted by microbes to urobilinoids, which are reduced to the predominant pigment in feces, stercobilin, or reabsorbed. The function of urobilinoids in the gut or their physiological relevance of reabsorption is not well understood. In this review, we discuss the relationship of hepatic bilirubin signaling to the intestinal microbiota and its regulation of the liver-gut axis, as well as its capacity to mediate these processes.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 84 条
[31]  
Konícková R, 2012, ACTA BIOCHIM POL, V59, P289
[32]  
Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]
[33]   Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: A favorable endogenous response [J].
Kumar, Ramesh ;
Rastogi, Archana ;
Maras, J. S. ;
Sarin, Shiv Kumar .
CLINICAL BIOCHEMISTRY, 2012, 45 (03) :272-274
[34]   Our Gut Microbiome: The Evolving Inner Self [J].
Kundu, Parag ;
Blacher, Eran ;
Elinav, Eran ;
Pettersson, Sven .
CELL, 2017, 171 (07) :1481-1493
[35]  
Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383
[36]   INTESTINAL ABSORPTION OF BILE PIGMENTS .3. ENTEROHEPATIC CIRCULATION OF UROBILINOGEN IN RAT [J].
LESTER, R ;
SCHMID, R .
JOURNAL OF CLINICAL INVESTIGATION, 1965, 44 (05) :722-&
[37]   Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham heart study [J].
Lin, Jing-Ping ;
O'Donnell, Christopher J. ;
Schwaiger, Johannes P. ;
Cupples, L. Adrienne ;
Lingenhel, Arno ;
Hunt, Steven C. ;
Yang, Song ;
Kronenberg, Florian .
CIRCULATION, 2006, 114 (14) :1476-1481
[38]   Variants in the UGT1A1 Gene and the Risk of Pediatric Nonalcoholic Fatty Liver Disease [J].
Lin, Yu-Cheng ;
Chang, Pi-Feng ;
Hu, Fu-Chang ;
Chang, Mei-Hwei ;
Ni, Yen-Hsuan .
PEDIATRICS, 2009, 124 (06) :E1221-E1227
[39]   Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels [J].
Liu, Jinfeng ;
Dong, Huansheng ;
Zhang, Yong ;
Cao, Mingjun ;
Song, Lili ;
Pan, Qingjie ;
Bulmer, Andrew ;
Adams, David B. ;
Dong, Xiao ;
Wang, Hongjun .
SCIENTIFIC REPORTS, 2015, 5
[40]   Bilirubin suppresses Th17 immunity in colitis by upregulating CD39 [J].
Longhi, Maria Serena ;
Vuerich, Marta ;
Kalbasi, Alireza ;
Kenison, Jessica E. ;
Yeste, Ada ;
Csizmadia, Eva ;
Vaughn, Byron ;
Feldbrugge, Linda ;
Mitshuhashi, Shuji ;
Wegiel, Barbara ;
Otterbein, Leo ;
Moss, Alan ;
Quintana, Francisco J. ;
Robson, Simon C. .
JCI INSIGHT, 2017, 2 (09)